Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
aflibercept (zaltrap) (1 trial)
Macular Degeneration (Phase 4)
Trials (1 total)
Trial APIs (1 total)